Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.52
+0.26981.11%
Post-market: 23.58-0.9404-3.84%16:04 EDT
Volume:2K
Turnover:37.85K
Market Cap:5.64M
PE:- -
High:24.52
Open:24.22
Low:23.58
Close:24.25
52wk High:27.94
52wk Low:22.89
Shares:230.00K
Float Shares:230.00K
Volume Ratio:1.31
T/O Rate:0.68%
Dividend:0.41
Dividend Rate:1.68%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims Shares Have The Bull Case Changed After Privacy And Billing Lawsuits

Simply Wall St.
·
Yesterday

Moderately bullish activity in Hims and Hers Health with shares up 7.5%

TIPRANKS
·
Yesterday

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

TIPRANKS
·
Yesterday

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Yesterday

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Oct 09

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Oct 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Oct 09

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
Oct 09

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Oct 09

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Oct 09

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Oct 09

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Oct 09

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Advance Understanding of the Interconnected Immune and Metabolic Biology in Adults with Psoriasis and Obesity

THOMSON REUTERS
·
Oct 09

Novo Nordisk's Wegovy Pill to Buoy Sales, but Investors Likely to Stay Sidelined

Dow Jones
·
Oct 09

Top 3 Biotech Stocks To Watch In October 2026

Simply Wall St.
·
Oct 09

Citi Lowers Novo Nordisk Price Target to DKK 296: Oral Weight-Loss Pill Sales Outlook Improves, but Margin Growth Remains Weak

Deep News
·
Oct 09

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 4.89%

TIPRANKS
·
Oct 09

Lilly’s Oral Orforglipron Trial Targets Early Obesity Risks, Raising the Stakes in Weight-Loss Pharma

TIPRANKS
·
Oct 09

Novo Nordisk Wraps Up Real World Joint Health Study for Esperoct in Haemophilia A

TIPRANKS
·
Oct 09

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Oct 09